| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33867130_HAS_TOPIC_C0009528> <https://research.tib.eu/covid-19/entity/33867130_HAS_TOPIC_C0035222> <https://research.tib.eu/covid-19/entity/33867130_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33867130_HAS_TOPIC_C0748355> <https://research.tib.eu/covid-19/entity/33867130_HAS_TOPIC_C0852283> <https://research.tib.eu/covid-19/entity/33867130_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33867130_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/33867130_HAS_TOPIC_C5392141> <https://research.tib.eu/covid-19/entity/33867130_HAS_TOPIC_C5392184>
?:authorAffiliation	[\'Evotec (UK) Ltd, Abingdon, UK. Electronic address: tahsin.kellici@evotec.com.\', \'Evotec (UK) Ltd, Abingdon, UK.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Bodkin_Michael_J> <https://research.tib.eu/covid-19/entity/Kellici_Tahsin_F> <https://research.tib.eu/covid-19/entity/Pilka_Ewa_S>
?:doi	S0165-6147(21)00053-510.1016/j.tips.2021.03.006
?:doi	<https://research.tib.eu/covid-19/entity/S0165-6147%2821%2900053-510.1016/j.tips.2021.03.006>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Comment> <https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	Trends in pharmacological sciences
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33867130>
?:pmid	<https://research.tib.eu/covid-19/entity/33867130>
?:pmid	33867130
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	4.794
?:rankingScore_hIndex	195
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0030190_ASSOCIATED_WITH_C0005779>
?:title	Therapeutic Potential of Targeting Plasminogen Activator Inhibitor-1 in COVID-19.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/33867130>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/33867130>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all